1552O Chemotherapy-induced peripheral neuropathy (CIPN) prevention trial evaluating the efficacy of hand-cooling and compression in patients undergoing taxan-based (neo-)adjuvant chemotherapy for primary breast cancer: First results of the prospective, randomized POLAR trial

• DOI: 10.1016/j.annonc.2022.07.1646
• Publication Date: 2022-09-13T22:20:48Z
• Authors: L. Michel; P. Romar; M. Feisst; D. Hamberger; D. Schwarz; E. Kurre; E. Klein; M.O. Breckwoldt; A. Priester; M. Weiler; K. Smetanay; C. Fremd; D. Jäger; M. Bendszus; F. Marmé; A. Schneeweiss
• Keywords: Chemotherapy-Induced Peripheral Neuropathy; Clinical endpoint; Taxane